BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14512536)

  • 1. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.
    Sarobe P; Lasarte JJ; Zabaleta A; Arribillaga L; Arina A; Melero I; Borrás-Cuesta F; Prieto J
    J Virol; 2003 Oct; 77(20):10862-71. PubMed ID: 14512536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
    Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.
    Sarobe P; Lasarte JJ; Casares N; López-Díaz de Cerio A; Baixeras E; Labarga P; García N; Borrás-Cuesta F; Prieto J
    J Virol; 2002 May; 76(10):5062-70. PubMed ID: 11967322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
    Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
    Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
    Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
    Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.
    Dolganiuc A; Kodys K; Kopasz A; Marshall C; Do T; Romics L; Mandrekar P; Zapp M; Szabo G
    J Immunol; 2003 Jun; 170(11):5615-24. PubMed ID: 12759441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.
    Encke J; Findeklee J; Geib J; Pfaff E; Stremmel W
    Clin Exp Immunol; 2005 Nov; 142(2):362-9. PubMed ID: 16232225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O; Lasarte JJ; Wilkinson G; Grace K; Clarke B; Borrás-Cuesta F; Prieto J
    Hepatology; 1997 Feb; 25(2):470-7. PubMed ID: 9021966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.
    Wintermeyer P; Gehring S; Eken A; Wands JR
    J Viral Hepat; 2010 Oct; 17(10):705-13. PubMed ID: 20002303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
    Wang QC; Feng ZH; Zhou YX; Nie QH
    World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
    J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction.
    Aloman C; Gehring S; Wintermeyer P; Kuzushita N; Wands JR
    Gastroenterology; 2007 Feb; 132(2):698-708. PubMed ID: 17258730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
    Díaz-Valdés N; Manterola L; Belsúe V; Riezu-Boj JI; Larrea E; Echeverria I; Llópiz D; López-Sagaseta J; Lerat H; Pawlotsky JM; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
    Hepatology; 2011 Jan; 53(1):23-31. PubMed ID: 21154952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation.
    Thumann C; Schvoerer E; Abraham JD; Bohbot A; Stoll-Keller F; Aubertin AM; Kieny MP
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):59-68. PubMed ID: 18341978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
    J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.